PsyCan Comments on FDA Decision Re: Lykos MDMA-Assisted Therapy Application

OTTAWA, Ontario, Aug. 09, 2024 (GLOBE NEWSWIRE) — PsyCan, the not-for-profit trade association for the legal Canadian psychedelic medicine, today commented on the U.S. Food and Drug Administration (“FDA”) decision on the New Drug Application by